Academic article

• Brattås, Marte Karen; Hemsing, Anette Lodvir; Rye, Kristin Paulsen et al. (2022). Heterogeneity of patient-derived acute myeloid leukemia cells subjected to SYK in vitro inhibition. (external link)
• Brattås, Marte Karen; Reikvam, Håkon; Tvedt, Tor Henrik Anderson et al. (2019). Dasatinib is an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. (external link)
• Brattås, Marte Karen; Reikvam, Håkon; Tvedt, Tor Henrik Anderson et al. (2019). Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. (external link)
• Brattås, Marte Karen; Lilleeng, Kyrre Flattun; Hovland, Randi et al. (2018). Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis. (external link)
• Brattås, Marte Karen; Reikvam, Håkon (2017). Ringsideroblaster. (external link)

Article in business/trade/industry journal

• Brattås, Marte Karen; Gjelberg, Helge Kollsete; Dizdar, Vernesa et al. (2019). En kvinne i 40-?rene med bekkensmerter og uklare MR-funn. (external link)

Academic literature review

• Brattås, Marte Karen; Reikvam, Håkon; Tvedt, Tor Henrik Anderson et al. (2019). Precision medicine for TP53-mutated acute myeloid leukemia. (external link)
• Bartaula-Brevik, Sushma; Brattås, Marte Karen; Tvedt, Tor Henrik Anderson et al. (2018). Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia. (external link)

See a complete overview of publications in Cristin.